Trial intelligence / Profile preview

Fetal MCA Doppler with Magnesium Sulfate in Preterm Birth

NCT02506894Phase 1Completed

Sponsor
Cairo University
Start
Jul 2015
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in preterm birth comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Changes in Fetal Middle Cerebral Artery Doppler Indices at 3 months. Started Jul 2015; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT02506894.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02506894.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call